Pharma companies are expected to see a decline in their first-quarter margins despite experiencing revenue growth. However, the performance of individual companies may vary, with some reporting strong earnings beats and others facing headwinds. The overall impact of various factors, including potential price hikes and global events, on the pharmaceutical industry's margins remains uncertain.